NM_005629.4:c.1162G>A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The NM_005629.4(SLC6A8):c.1162G>A (p.Ala388Thr) variant in SLC6A8 is a missense variant predicted to cause substitution of Threonine for Alanine at amino acid 338 (p.Ala338Thr). There is a ClinVar entry for this variant (Variation ID:436771). This variant is found with an allele frequency of 0.003854 in gnomADv2.1.1 with 17 hemizygotes present in that population database. Given the presence of >10 hemizygotes in gnomADv2.1.1 and an allele frequency >0.002, the stand alone benign criteria BA1 is applicable for this variant. In summary, this variant meets the criteria to be classified as Benign for Creatine Transporter Deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel (Specifications Version 1.1.0; ; classification approved Feb 23, 2023): BA1 LINK:https://erepo.genome.network/evrepo/ui/classification/CA10549443/MONDO:0010305/027

Frequency

Genomes: 𝑓 0.00030 ( 0 hom., 8 hem., cov: 24)
Exomes 𝑓: 0.00048 ( 1 hom. 153 hem. )

Consequence

SLC6A8
NM_005629.4 missense

Scores

7
7
3

Clinical Significance

Benign reviewed by expert panel U:1B:7

Conservation

PhyloP100: 9.85

Publications

4 publications found
Variant links:
Genes affected
SLC6A8 (HGNC:11055): (solute carrier family 6 member 8) The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
SLC6A8 Gene-Disease associations (from GenCC):
  • creatine transporter deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A8NM_005629.4 linkc.1162G>A p.Ala388Thr missense_variant Exon 8 of 13 ENST00000253122.10 NP_005620.1 P48029-1X5D9C4
SLC6A8NM_001142805.2 linkc.1132G>A p.Ala378Thr missense_variant Exon 8 of 13 NP_001136277.1 P48029Q59EV7
SLC6A8NM_001142806.1 linkc.817G>A p.Ala273Thr missense_variant Exon 8 of 13 NP_001136278.1 P48029-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A8ENST00000253122.10 linkc.1162G>A p.Ala388Thr missense_variant Exon 8 of 13 1 NM_005629.4 ENSP00000253122.5 P48029-1

Frequencies

GnomAD3 genomes
AF:
0.000302
AC:
34
AN:
112742
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.0000967
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000279
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000642
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000432
Gnomad OTH
AF:
0.000657
GnomAD2 exomes
AF:
0.000330
AC:
39
AN:
118182
AF XY:
0.000321
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00109
Gnomad NFE exome
AF:
0.000547
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000479
AC:
504
AN:
1053227
Hom.:
1
Cov.:
32
AF XY:
0.000446
AC XY:
153
AN XY:
342745
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25128
American (AMR)
AF:
0.0000353
AC:
1
AN:
28368
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18659
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27609
South Asian (SAS)
AF:
0.0000200
AC:
1
AN:
50062
European-Finnish (FIN)
AF:
0.000911
AC:
34
AN:
37308
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2918
European-Non Finnish (NFE)
AF:
0.000561
AC:
459
AN:
818837
Other (OTH)
AF:
0.000203
AC:
9
AN:
44338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000301
AC:
34
AN:
112795
Hom.:
0
Cov.:
24
AF XY:
0.000229
AC XY:
8
AN XY:
34941
show subpopulations
African (AFR)
AF:
0.0000964
AC:
3
AN:
31106
American (AMR)
AF:
0.000278
AC:
3
AN:
10778
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2657
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3550
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2759
European-Finnish (FIN)
AF:
0.000642
AC:
4
AN:
6230
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.000432
AC:
23
AN:
53268
Other (OTH)
AF:
0.000649
AC:
1
AN:
1542
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000485
Hom.:
6
Bravo
AF:
0.000234
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000453
AC:
3
ExAC
AF:
0.0000943
AC:
10

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:7
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Feb 22, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Creatine transporter deficiency Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 23, 2023
ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The NM_005629.4(SLC6A8):c.1162G>A (p.Ala388Thr) variant in SLC6A8 is a missense variant predicted to cause substitution of Threonine for Alanine at amino acid 338 (p.Ala338Thr). There is a ClinVar entry for this variant (Variation ID:436771). This variant is found with an allele frequency of 0.003854 in gnomADv2.1.1 with 17 hemizygotes present in that population database. Given the presence of >10 hemizygotes in gnomADv2.1.1 and an allele frequency >0.002, the stand alone benign criteria BA1 is applicable for this variant. In summary, this variant meets the criteria to be classified as Benign for Creatine Transporter Deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel (Specifications Version 1.1.0; ; classification approved Feb 23, 2023): BA1 -

not provided Benign:2
Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC6A8: PP2, BS2 -

Mar 03, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Previously reported as a non-pathogenic variant in a male with intellectual disability and normal creatine uptake in cultured skin fibroblasts (Betsalel et al, 2011).; This variant is associated with the following publications: (PMID: 28758966, 22281021, 26684475, 20717164, 25861866) -

Creatine deficiency syndrome 1 Benign:1
Jan 24, 2020
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Nov 05, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.66
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Pathogenic
0.41
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.46
T;.
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.86
D;D
M_CAP
Pathogenic
0.34
D
MetaRNN
Benign
0.41
T;T
MetaSVM
Benign
-0.36
T
MutationAssessor
Uncertain
2.1
M;.
PhyloP100
9.8
PrimateAI
Uncertain
0.77
T
PROVEAN
Uncertain
-3.5
D;D
REVEL
Pathogenic
0.84
Sift
Uncertain
0.0010
D;D
Sift4G
Uncertain
0.020
D;T
Polyphen
0.97
D;.
Vest4
0.61
MVP
0.93
MPC
2.3
ClinPred
0.31
T
GERP RS
4.8
PromoterAI
-0.045
Neutral
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.6
Varity_R
0.83
gMVP
0.82
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374163604; hg19: chrX-152959380; API